News & Blog
Our Sophomore Year: A Review of 2022
BioCentury: BioCentury’s 2022 class of emerging companies
Looking Ahead Series: Developing Insights from the MEC Council and the Brightest Minds
Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009
Aspen Neuroscience Inks $40 Million Debt Deal with Silicon Valley Bank
Delivery Innovation hits Gene Therapy
Endpoints News: Gene therapy goes acoustic as ARCH-backed biotech launches with ultrasound gene delivery platform
Multi-omics Startup Pleno Inc. Continues to Strengthen its Board of Directors
MERIT: Funding “Hard to Fund” Science with MERIT
Multi-omics Startup Pleno Inc. Expands Leadership Team to Accelerate Development of its Novel Hypercoding Technology